Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CL vs GSK✓SelectedUSD · GSKCL vs GSK performance historyLatest closeAs of+1.32%11/16
Stock and ETF performance explorer

CL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+91.6%
GSK return
+107.3%
Excess return
-15.6%
Maximum drawdown
-29.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+1.3%-0.1%+1.4%+1.4%
7D+3.1%-1.3%+4.4%+3.6%
30D+7.9%+2.7%+5.2%+6.9%
3M+10.5%+2.7%+7.7%+9.3%
6M+15.9%+3.3%+12.6%+14.3%
YTD+30.9%+6.5%+24.4%+27.2%
1Y+32.5%+10.7%+21.8%+27.0%
3Y+42.5%+64.4%-21.9%+16.1%
5Y+46.0%+46.7%-0.7%+22.3%
10Y+91.6%+109.4%-17.7%+36.8%
All+91.6%+107.3%-15.6%+36.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling